A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions

Clinical trial NCT05397834 · UNKNOWN

Trial details

NCT number: NCT05397834
Sponsor: Respirent Pharmaceuticals Co Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Bioequivalence

Start date: 2022-05-11
Primary completion: 2022-06-21
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.